Periprocedural safety profile of peroral endoscopic myotomy (POEM)-a retrospective analysis of adverse events according to two different classifications.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
02 2023
Historique:
received: 06 12 2021
accepted: 11 09 2022
pubmed: 29 9 2022
medline: 25 2 2023
entrez: 28 9 2022
Statut: ppublish

Résumé

Peroral endoscopic myotomy (POEM) is nowadays a standard method for treatment of achalasia; nevertheless, it remains an invasive intervention with corresponding risk of adverse events (AEs). The classification and grading of AEs are still a matter of discussion. The aim of our retrospective study was to assess the occurrence of all "undesirable" events and "true" adverse events in patients undergoing POEM and to compare the outcomes when either Clavien-Dindo classification (CDC) or American Society of Gastrointestinal Endoscopy (ASGE) lexicon classification applied. This was a retrospective analysis of prospectively managed database of all patients who had undergone POEM between December 2012 and August 2018. We assessed the pre-, peri-, and early-postoperative (up to patient's discharge) undesirable events (including those not fulfilling criteria for AEs) and "true" AEs according the definition in either of the classifications. A total of 231 patients have successfully undergone 244 POEM procedures (13 × re-POEM). Twenty-nine procedures (11.9%) passed uneventfully, while in 215 procedures (88.1%), a total of 440 undesirable events occurred. The CDC identified 27 AEs (17 minor, 10 major) occurring in 23/244 (9.4%) procedures. The ASGE lexicon identified identical 27 AEs (21 mild or moderate, 6 severe or fatal) resulting in the severity distribution of AEs being the only difference between the two classifications. Only the absence of previous treatment was found to be a risk factor [p = 0.047, OR with 95% CI: 4.55 (1.02; 20.25)] in the combined logistic regression model. Undesirable events are common in patients undergoing POEM but the incidence of true AEs is low according to both classifications. Severe adverse events are infrequent irrespective of the classification applied. CDC may be more appropriate than ASGE lexicon for classifying POEM-related AEs given a surgical nature of this procedure.

Sections du résumé

BACKGROUND
Peroral endoscopic myotomy (POEM) is nowadays a standard method for treatment of achalasia; nevertheless, it remains an invasive intervention with corresponding risk of adverse events (AEs). The classification and grading of AEs are still a matter of discussion. The aim of our retrospective study was to assess the occurrence of all "undesirable" events and "true" adverse events in patients undergoing POEM and to compare the outcomes when either Clavien-Dindo classification (CDC) or American Society of Gastrointestinal Endoscopy (ASGE) lexicon classification applied.
METHODS
This was a retrospective analysis of prospectively managed database of all patients who had undergone POEM between December 2012 and August 2018. We assessed the pre-, peri-, and early-postoperative (up to patient's discharge) undesirable events (including those not fulfilling criteria for AEs) and "true" AEs according the definition in either of the classifications.
RESULTS
A total of 231 patients have successfully undergone 244 POEM procedures (13 × re-POEM). Twenty-nine procedures (11.9%) passed uneventfully, while in 215 procedures (88.1%), a total of 440 undesirable events occurred. The CDC identified 27 AEs (17 minor, 10 major) occurring in 23/244 (9.4%) procedures. The ASGE lexicon identified identical 27 AEs (21 mild or moderate, 6 severe or fatal) resulting in the severity distribution of AEs being the only difference between the two classifications. Only the absence of previous treatment was found to be a risk factor [p = 0.047, OR with 95% CI: 4.55 (1.02; 20.25)] in the combined logistic regression model.
CONCLUSION
Undesirable events are common in patients undergoing POEM but the incidence of true AEs is low according to both classifications. Severe adverse events are infrequent irrespective of the classification applied. CDC may be more appropriate than ASGE lexicon for classifying POEM-related AEs given a surgical nature of this procedure.

Identifiants

pubmed: 36171448
doi: 10.1007/s00464-022-09621-z
pii: 10.1007/s00464-022-09621-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1242-1251

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, Satodate H, Odaka N, Itoh H, Kudo S (2010) Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 42(4):265–271. https://doi.org/10.1055/s-0029-1244080
doi: 10.1055/s-0029-1244080 pubmed: 20354937
Werner YB, Hakanson B, Martinek J, Repici A, von Rahden BHA, Bredenoord AJ, Bisschops R, Messmann H, Vollberg MC, Noder T, Kersten JF, Mann O, Izbicki J, Pazdro A, Fumagalli U, Rosati R, Germer CT, Schijven MP, Emmermann A, von Renteln D, Fockens P, Boeckxstaens G, Rösch T (2019) Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med 381(23):2219–2229. https://doi.org/10.1056/NEJMoa1905380
doi: 10.1056/NEJMoa1905380 pubmed: 31800987
Shiwaku H, Inoue H, Onimaru M, Minami H, Sato H, Sato C, Tanaka S, Ogawa R, Okushima N (2020) Multicenter collaborative retrospective evaluation of peroral endoscopic myotomy for esophageal achalasia: analysis of data from more than 1300 patients at eight facilities in Japan. Surg Endosc 34(1):464–468. https://doi.org/10.1007/s00464-019-06833-8
doi: 10.1007/s00464-019-06833-8 pubmed: 31183791
Shiwaku H, Inoue H, Sato H, Onimaru M, Minami H, Tanaka S, Sato C, Ogawa R, Okushima N, Yokomichi H (2020) Peroral endoscopic myotomy for achalasia: a prospective multicenter study in Japan. Gastrointest Endosc 91(5):1037-1044.e2. https://doi.org/10.1016/j.gie.2019.11.020
doi: 10.1016/j.gie.2019.11.020 pubmed: 31759035
Hungness ES, Sternbach JM, Teitelbaum EN, Kahrilas PJ, Pandolfino JE, Soper NJ (2016) Per-oral endoscopic myotomy (POEM) after the learning curve: durable long-term results with a low complication rate. Ann Surg 264(3):508–517. https://doi.org/10.1097/SLA.0000000000001870
doi: 10.1097/SLA.0000000000001870 pubmed: 27513156
Ponds FA, Fockens P, Lei A, Neuhaus H, Beyna T, Kandler J, Frieling T, Chiu PWY, Wu JCY, Wong VWY, Costamagna G, Familiari P, Kahrilas PJ, Pandolfino JE, Smout AJPM, Bredenoord AJ (2019) Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA 322(2):134–144. https://doi.org/10.1001/jama.2019.8859
doi: 10.1001/jama.2019.8859 pubmed: 31287522 pmcid: 6618792
Oude Nijhuis RAB, Zaninotto G, Roman S, Boeckxstaens GE, Fockens P, Langendam MW, Plumb AA, Smout A, Targarona EM, Trukhmanov AS, Weusten B, Bredenoord AJ (2020) European guidelines on achalasia: United European gastroenterology and European society of neurogastroenterology and motility recommendations. United Eur Gastroenterol J 8(1):13–33. https://doi.org/10.1177/2050640620903213
doi: 10.1177/2050640620903213
Weusten BLAM, Barret M, Bredenoord AJ, Familiari P, Gonzalez JM, van Hooft JE, Ishaq S, Lorenzo-Zúñiga V, Louis H, van Meer S, Neumann H, Pohl D, Prat F, von Renteln D, Savarino E, Sweis R, Tack J, Tutuian R, Martinek J (2020) Endoscopic management of gastrointestinal motility disorders—part 1: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy 52(6):498–515. https://doi.org/10.1055/a-1160-5549
doi: 10.1055/a-1160-5549 pubmed: 32375192
Patel K, Abbassi-Ghadi N, Markar S, Kumar S, Jethwa P, Zaninotto G (2016) Peroral endoscopic myotomy for the treatment of esophageal achalasia: systematic review and pooled analysis. Dis Esophagus 29(7):807–819. https://doi.org/10.1111/dote.12387
doi: 10.1111/dote.12387 pubmed: 26175119
Nabi Z, Reddy DN, Ramchandani M (2018) Adverse events during and after per-oral endoscopic myotomy: prevention, diagnosis, and management. Gastrointest Endosc 87(1):4–17. https://doi.org/10.1016/j.gie.2017.09.029
doi: 10.1016/j.gie.2017.09.029 pubmed: 28987545
Werner YB, von Renteln D, Noder T, Schachschal G, Denzer UW, Groth S, Nast JF, Kersten JF, Petzoldt M, Adam G, Mann O, Repici A, Hassan C, Rösch T (2017) Early adverse events of per-oral endoscopic myotomy. Gastrointest Endosc 85(4):708-718.e2. https://doi.org/10.1016/j.gie.2016.08.033
doi: 10.1016/j.gie.2016.08.033 pubmed: 27609778
Chen YI, Inoue H, Ujiki M, Draganov PV, Colavita P, Mion F, Romanelli J, Chiu P, Balassone V, Patel L, Abbas A, Yang D, Dunst C, Pioche M, Roman S, Rivory J, Ponchon T, Desilets D, Maselli R, Onimaru M, Nakamura J, Hata Y, Hajiyeva G, Ismail A, Ngamruengphong S, Bukhari M, Chavez YH, Kumbhari V, Repici A, Khashab MA (2018) An international multicenter study evaluating the clinical efficacy and safety of per-oral endoscopic myotomy in octogenarians. Gastrointest Endosc 87(4):956–961. https://doi.org/10.1016/j.gie.2017.02.007
doi: 10.1016/j.gie.2017.02.007 pubmed: 28235595
Zhang XC, Li QL, Xu MD, Chen SY, Zhong YS, Zhang YQ, Chen WF, Ma LL, Qin WZ, Hu JW, Cai MY, Yao LQ, Zhou PH (2016) Major perioperative adverse events of peroral endoscopic myotomy: a systematic 5-year analysis. Endoscopy 48(11):967–978. https://doi.org/10.1055/s-0042-110397
doi: 10.1055/s-0042-110397 pubmed: 27448052
Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A Jr, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ (2010) A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 71(3):446–454. https://doi.org/10.1016/j.gie.2009.10.027
doi: 10.1016/j.gie.2009.10.027 pubmed: 20189503
Chavan R, Nabi Z, Reddy DN (2020) Adverse events associated with third space endoscopy: diagnosis and management. Int J Gastrointest Interv 9:86–97. https://doi.org/10.18528/ijgii200010
doi: 10.18528/ijgii200010
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123
NOSCAR POEM White Paper Committee, Stavropoulos SN, Desilets DJ, Fuchs KH, Gostout CJ, Haber G, Inoue H, Kochman ML, Modayil R, Savides T, Scott DJ, Swanstrom LL, Vassiliou MC. 2014 Per-oral endoscopic myotomy white paper summary. Gastrointest Endosc. 80(1):1–15. Doi: https://doi.org/10.1016/j.gie.2014.04.014 .
Haito-Chavez Y, Inoue H, Beard KW, Draganov PV, Ujiki M, Rahden BHA, Desai PN, Pioche M, Hayee B, Haji A, Saxena P, Reavis K, Onimaru M, Balassone V, Nakamura J, Hata Y, Yang D, Pannu D, Abbas A, Perbtani YB, Patel LY, Filser J, Roman S, Rivory J, Mion F, Ponchon T, Perretta S, Wong V, Maselli R, Ngamruengphong S, Chen YI, Bukhari M, Hajiyeva G, Ismail A, Pieratti R, Kumbhari V, Galdos-Cardenas G, Repici A, Khashab MA (2017) Comprehensive analysis of adverse events associated with per oral endoscopic myotomy in 1826 patients: an international multicenter study. Am J Gastroenterol 112(8):1267–1276. https://doi.org/10.1038/ajg.2017.139
doi: 10.1038/ajg.2017.139 pubmed: 28534521
Martinek J, Svecova H, Vackova Z, Dolezel R, Ngo O, Krajciova J, Kieslichova E, Janousek R, Pazdro A, Harustiak T, Zdrhova L, Loudova P, Stirand P, Spicak J (2018) Per-oral endoscopic myotomy (POEM): mid-term efficacy and safety. Surg Endosc 32(3):1293–1302. https://doi.org/10.1007/s00464-017-5807-3
doi: 10.1007/s00464-017-5807-3 pubmed: 28799005
Parsa N, Haito-Chavez Y, Gutierrez OIB et al (2018) Sa1907 Classification and grading of adverse events related to peroral endoscopic myotomy (poem): a comparison between the American society of gastrointestinal endoscopy lexicon and the Clavien-Dindo classification. Gastrointest Endosc. https://doi.org/10.1016/j.gie.2018.04.429
doi: 10.1016/j.gie.2018.04.429
Hucl T, Uchytilova E, Markvartova J, Tomasek P, Kieslichova E, Spicak J, Martinek J (2020) Cardiac arrest as a fatal periprocedural complication of peroral endoscopic myotomy (POEM). Endoscopy 52(11):E411–E412. https://doi.org/10.1055/a-1149-1055
doi: 10.1055/a-1149-1055 pubmed: 32330949
Ross SW, Oommen B, Wormer BA, Walters AL, Matthews BD, Heniford BT, Augenstein VA (2015) National outcomes of laparoscopic heller myotomy: operative complications and risk factors for adverse events. Surg Endosc 29(11):3097–3105. https://doi.org/10.1007/s00464-014-4054-0
doi: 10.1007/s00464-014-4054-0 pubmed: 25588362
Costantini A, Familiari P, Costantini M, Salvador R, Valmasoni M, Capovilla G, Landi R, Mangiola F, Provenzano L, Briscolini D, Merigliano S, Costamagna G (2020) Poem versus laparoscopic heller myotomy in the treatment of esophageal achalasia: a case-control study from two high volume centers using the propensity score. J Gastrointest Surg 24(3):505–515. https://doi.org/10.1007/s11605-019-04465-w
doi: 10.1007/s11605-019-04465-w pubmed: 31848870
Martins RK, Ribeiro IB, de Moura DTH, Hathorn KE, Bernardo WM, de Moura EGH (2020) Peroral (POEM) or surgical myotomy for the treatment of achalasia: a systematic review and meta-analysis. Arq Gastroenterol 57(1):79–86. https://doi.org/10.1590/S0004-2803.202000000-14
doi: 10.1590/S0004-2803.202000000-14 pubmed: 32294740
Benias PC, Korrapati P, Raphael KL, D’Souza LS, Inamdar S, Trindade AJ, Lee C, Kumbhari V, Sejpal DV, Okolo P, Khashab MA, Miller L, Carr-Locke D (2019) Safety and feasibility of performing peroral endoscopic myotomy as an outpatient procedure with same-day discharge. Gastrointest Endosc 90(4):570–578. https://doi.org/10.1016/j.gie.2019.04.247
doi: 10.1016/j.gie.2019.04.247 pubmed: 31078571
Tan S, Zhong C, Ren Y, Luo X, Xu J, Fu X, Peng Y, Tang X (2021) Efficacy and safety of peroral endoscopic myotomy in achalasia patients with failed previous intervention: a systematic review and meta-analysis. Gut Liver 15(2):153–167. https://doi.org/10.5009/gnl19234
doi: 10.5009/gnl19234 pubmed: 32616678
Huang Z, Cui Y, Li Y, Chen M, Xing X (2021) Peroral endoscopic myotomy for patients with achalasia with previous heller myotomy: a systematic review and meta-analysis. Gastrointest Endosc 93(1):47-56.e5. https://doi.org/10.1016/j.gie.2020.05.056
doi: 10.1016/j.gie.2020.05.056 pubmed: 32522483
Crespin OM, Liu LWC, Parmar A, Jackson TD, Hamid J, Shlomovitz E, Okrainec A (2017) Safety and efficacy of POEM for treatment of achalasia: a systematic review of the literature. Surg Endosc 31(5):2187–2201. https://doi.org/10.1007/s00464-016-5217-y
doi: 10.1007/s00464-016-5217-y pubmed: 27633440
Talukdar R, Inoue H, Nageshwar RD (2015) Efficacy of peroral endoscopic myotomy (POEM) in the treatment of achalasia: a systematic review and meta-analysis. Surg Endosc 29(11):3030–3046. https://doi.org/10.1007/s00464-014-4040-6
doi: 10.1007/s00464-014-4040-6 pubmed: 25539695

Auteurs

Dagmar Simkova (D)

Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine IKEM, Videnska 1921, 140 21, Prague 4, Czech Republic.

Jan Mares (J)

Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine IKEM, Videnska 1921, 140 21, Prague 4, Czech Republic.

Zuzana Vackova (Z)

Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine IKEM, Videnska 1921, 140 21, Prague 4, Czech Republic.

Tomas Hucl (T)

Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine IKEM, Videnska 1921, 140 21, Prague 4, Czech Republic.

Petr Stirand (P)

Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine IKEM, Videnska 1921, 140 21, Prague 4, Czech Republic.

Eva Kieslichova (E)

Department of Anesthesiology and Intensive Care, Institute for Clinical and Experimental Medicine IKEM, Videnska 1921, 140 21, Prague, Czech Republic.

Ondrej Ryska (O)

Royal Lancaster Infirmary, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, UK.

Julius Spicak (J)

Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine IKEM, Videnska 1921, 140 21, Prague 4, Czech Republic.

Sylvia Drazilova (S)

2Nd Department of Internal Medicine, PJ Safarik University and L. Pasteur University Hospital, Trieda SNP 1, 040 11, Kosice, Slovakia.

Eduard Veseliny (E)

2Nd Department of Internal Medicine, PJ Safarik University and L. Pasteur University Hospital, Trieda SNP 1, 040 11, Kosice, Slovakia.

Jan Martinek (J)

Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine IKEM, Videnska 1921, 140 21, Prague 4, Czech Republic. jan.martinek@volny.cz.
Institute of Physiology, 1St Faculty of Medicine, Charles University, Prague, Czech Republic. jan.martinek@volny.cz.
Faculty of Medicine, Ostrava University, Ostrava, Czech Republic. jan.martinek@volny.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH